Skip to main content

Management of cesarean section in a patient with Fontan circulation: a case report of dramatic reduction of maternal oxygen consumption after delivery

Abstract

Background

The anesthetic management of cesarean sections in Fontan-palliated parturients requires strict hemodynamic control. However, patient management with central venous oxygen saturation (ScvO2) and oxygen consumption (VO2) has never been reported.

Case presentation

A 30-year-old woman, who had received a total cavopulmonary connection for tricuspid atresia, was planned to undergo cesarean section at 38 weeks’ gestation. During combined spinal-epidural anesthesia, ScvO2 in addition to arterial pressure-based cardiac output (APCO) and central venous pressure (CVP) was monitored, and the change of VO2 was evaluated. After delivery, her APCO was almost unchanged. However, her ScvO2 increased dramatically from 42.1 to 67.3% and her CVP increased from 9 to 11 mm Hg. The calculated mean maternal VO2 changed from 443 to 295 mL/min.

Conclusions

In a cesarean section for a Fontan-palliated parturient, ScvO2 dramatically increased and maternal VO2 decreased by more than 25% after delivery.

Background

The long-term survival rate of patients with congenital heart disease (CHD) has been improved through progress in surgical techniques and multidisciplinary perioperative management methods [1, 2]. Accordingly, the number of women with CHD who experience pregnancy and delivery is increasing [3, 4]. Fontan physiology is characterized by a single ventricle maintaining systemic and pulmonary circulation. Since pulmonary circulation in Fontan-palliated patients is driven by central venous pressure (CVP), these patients require a higher than normal CVP. Consequently, they are less tolerant to volume overload [5] and thus require strict circulation management during anesthesia.

During pregnancy, dynamic physiological changes occur, including an increase in cardiac output, oxygen consumption, and intravascular volume, making both pregnancy and delivery challenging for these patients [6]. Previous reports have described the perioperative management of cesarean section in Fontan-palliated parturients [7,8,9,10]. However, hemodynamic monitoring of central venous oxygen saturation (ScvO2) and oxygen consumption (VO2) during this procedure has never been reported. Here, we present the first case of a cesarean section during which ScvO2, arterial pressure-based cardiac output (APCO), and CVP were monitored in a patient with Fontan circulation. Furthermore, we examined perioperative changes in maternal VO2. Our report will contribute to the understanding of the hemodynamic and VO2 changes that occur during cesarean delivery in patients with Fontan circulation.

Case description

A female infant, diagnosed with tricuspid atresia (TA) type 1B (i.e., ventricular septal defect and pulmonary stenosis), underwent a balloon atrioseptostomy at 17 days of age and a Fontan operation at the age of 4 years. At age 12, she developed low percutaneous oxygen saturation (SpO2; 90%) and presented an exacerbation of symptoms, including cyanosis, clubbed fingers, and hepatomegaly. She underwent an extracardiac total cavopulmonary connection. Her postoperative CVP was 15 mm Hg. This procedure improved her New York Heart Association (NYHA) functional classification to class I. At 28 years old, her peak VO2, assessed by a cardiopulmonary exercise test, was 62.2% of that of healthy age-mates. Echocardiography indicated that her left ventricular ejection fraction (LVEF) was 64% without atrioventricular valvular regurgitation.

At age 30, she became pregnant and was referred to our hospital at 15 weeks’ gestation. Her usual anticoagulation therapy was changed from warfarin to aspirin because of the former’s teratogenic potential. A Holter electrocardiogram revealed a sinus rhythm of 91 beats/min without any episodes of arrhythmia. At 35 weeks’ gestation, she developed exertional dyspnea, followed by cyanosis (SpO2, 89% in room air), although she had an LVEF of 61% without left ventricular dilation. Her NYHA classification changed to class II. She was admitted to our hospital at 36 weeks’ gestation. Her blood hemoglobin decreased from 13.9 to 10.8 g/dL antenatally. Because her exercise capacity was 60% of that of healthy age-mates, a cesarean section was performed at 38 weeks’ gestation. Her anticoagulation therapy (intravenous unfractionated heparin, 10,000 U/day) was discontinued 6 h before surgery.

In the operating room, the patient’s electrocardiogram, SpO2, arterial blood pressure (ABP), and APCO were monitored via a left radial artery catheter (FloTrac SensorTM; Edwards Lifesciences Corporation, Irvine, CA, USA). Additionally, a central venous catheter (PreSep CatheterTM; Edwards Lifesciences) was inserted via the right internal jugular vein to monitor CVP and ScvO2 continuously. The tip of the central venous catheter was located just cephalad to the connection between the superior vena cava and the right pulmonary artery by chest X-ray examination. On room air, the patient’s SpO2, CVP, and ScvO2 levels were 92% (PaO2, 69 mm Hg), 10 mm Hg, and 52.2%, respectively (Table 1). After the initiation of oxygen administration at 5 L/min, she underwent combined spinal-epidural anesthesia in the left lateral position. An epidural catheter was inserted at T12/L1 level, after which 5 mg of hyperbaric-bupivacaine and 15 μg of fentanyl were administered intrathecally at L3/4 intervertebral space. Additionally, 10 mL of 2% lidocaine (200 mg) was administered via the epidural catheter, allowing a T4 anesthetic intervertebral space to be attained. Figure 1 shows her vital sign trends during anesthesia, including cardiac index (CI), CVP, and ScvO2.

Table 1 Perioperative hemodynamic parameters
Fig. 1
figure1

Trend of hemodynamic parameters during anesthesia. HR, heart rate; ABP, arterial blood pressure; SpO2, percutaneous oxygen saturation; ScvO2, central venous oxygen saturation; CI, cardiac index; CVP, central venous pressure

Ten minutes after the induction of anesthesia, she developed hypotension and her ScvO2 decreased to 38.6% compared to 54.6% before anesthesia. On the other hand, CO and CVP remained largely unchanged. Left uterine displacement was performed continuously after the induction of anesthesia. Additionally, phenylephrine was then infused intravenously at 0.5–1.5 mg/h. We selected not volume loading but vasoconstrictor for reversal of hypotension. Her ScvO2 levels recovered slightly with the increase of blood pressure. Nineteen minutes after induction, surgery was initiated. Ten minutes later, a healthy female infant weighing 2358 g was delivered. The infant’s Apgar scores at 1 and 5 min were 8 and 9, respectively. After delivery of the placenta, the patient’s ScvO2 increased from 45 to 83%, without blood pressure elevation; CVP increased from 10 to 14 mm Hg; and CI increased by 10%. VO2 values (Table 1) were calculated using the formula: VO2 (mL/min) = 1.34 × Hb (g/dL) × (SaO2 − ScvO2) × CO (L/min) × 10.

Surgery was completed without complications. For postoperative analgesia, 0.25% levobupivacaine was administered via the epidural catheter at 4 mL/h. Anesthesia and surgery lasted 69 and 50 min, respectively. During anesthesia, the estimated blood loss was 895 mL including amniotic fluid, and urine output was 220 mL. These were replaced with 750 mL of crystalloids.

The patient was transferred to the intensive care unit, where her CVP ranged from 11 to 15 mm Hg. Her brain natriuretic peptide levels increased by 14.2 to 26.7 pg/mL, although the cardiac silhouette on her chest X-ray did not show any dilation. For postoperative anticoagulation therapy, heparin was administered intravenously by 10,000 U/day. Her wound pain was well managed by epidural anesthesia. Heparin was stopped 6 h before the removal of the epidural catheter to prevent a hemorrhagic complication. She returned to the general ward on her first postoperative day and was discharged on the 9th postoperative day on 100 mg aspirin and 2.5 mg enalapril, daily.

Discussion

Here, we reported a case describing the use of combined spinal-epidural anesthesia for the management of cesarean section in a Fontan-palliated parturient. Because some adult CHD patients are at high risk for developing heart failure during pregnancy and postpartum [11], we focused on monitoring hemodynamic changes by measuring ScvO2 (used to calculate VO2), APCO, and CVP.

During the perinatal period, intravascular volume increases and systemic vascular resistance substantially decreases, increasing cardiac output up to 7.0 L/min 12]. For a Fontan-palliated parturient, it is difficult for cardiac output (CO) to be adequately increased, making this type of aggressive volume challenge potentially dangerous for this population [12]. After the induction of spinal-epidural anesthesia, T4 anesthetic level was attained and blood pressure decreased below 100 mm Hg. Critical vasodilation and decreased preload were evident due to a sympathetic block [13]. To treat the hypotension, phenylephrine was administered rather than using aggressive volume loading because autotransfusion (approximately 500 mL), induced by uterine contraction after delivery, could potentially cause volume overload. Consequently, fluid balance during the cesarean section was only + 200 mL, although the patient’s CVP increased from 10 to 14 mm Hg without increasing CO. Postoperative diuretic administration decreased CVP to 11 mm Hg, and heart failure did not occur. Since Fontan-palliated patients have a reduced tolerance to volume overload, restrictive fluid therapy may be the most suitable option during cesarean section.

Our patient was born with TA, and her systemic ventricle was the morphologic left ventricle after Fontan procedure. Before pregnancy, her heart function and exercise capacity were preserved. Before anesthesia induction, her APCO was 7.02 L/min, which is equivalent to 140% of the CO of non-pregnant women and the CO of normal parturients [14]. While the ability to increase CO tends to be compromised in Fontan-palliated patients [12], our patient’s cardiac function fortunately allowed for CO increase. Meanwhile, her ScvO2 decreased to 52.2% as a result of a substantial VO2 increase. At the time, the VO2 level (393 mL/min; Table 1) was equivalent to 160% of the value expected for non-pregnant women at rest, and more than 140% of that of a normal parturient [14]. This sharp increase in VO2 may have been caused by maternal stress. Furthermore, the critically low ScvO2 levels observed indicate that she was at the limit of her cardiac capacity. If her systemic ventricle had been the morphologic right ventricle, she would probably have had significant systemic heart failure during the perinatal period.

After anesthesia induction, the patient’s arterial blood pressure slightly decreased to 109/53 mm Hg and CO was 6.73 L/min. ScvO2 levels further decreased to 38.6%, while VO2 levels further increased to 543 mL/min (Table 1). These changes in ScvO2 and VO2 levels may have resulted from further maternal psychological stress. After the delivery, her CO increased by 10% and CVP increased from 10 to 14 mm Hg. Additionally, her ScvO2 increased from 42.1 to 67.3% and the calculated VO2 decreased to 256 mL/min. The latter is equivalent to the VO2 of a non-pregnant woman at rest. This change in VO2 suggests that fetus delivery and subsequent stress relief may substantially decrease maternal VO2 and restore it to normal levels.

The combined spinal-epidural anesthesia management in a cesarean section for a Fontan-palliated parturient with monitoring of ScvO2, APCO, and CVP was presented. Our report revealed maternal circulatory dynamics and VO2 changes during a cesarean section in a Fontan-palliated patient. Maternal VO2 was found to decrease substantially after the delivery of the fetus.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

CHD:

Congenital heart disease

CVP:

Central venous pressure

ScvO2 :

Central venous oxygen saturation

VO2 :

Oxygen consumption

APCO:

Arterial pressure-based cardiac output

TA:

Tricuspid atresia

NYHA:

New York Heart Association

LVEF:

Left ventricular ejection fraction

ABP:

Arterial blood pressure

CI:

Cardiac index

References

  1. 1.

    Uebing A, Steer PJ, Yentis SM, Gatzoulis MA. Pregnancy and congenital heart disease. BMJ. 2006;332:401.

    Article  Google Scholar 

  2. 2.

    Girod DA, Fontan F, Deville C, Ottenkamp J, Choussat A. Long term results after the Fontan operation for tricuspid atresia. Circulation. 1987;75:605–10.

    CAS  Article  Google Scholar 

  3. 3.

    Warnes CA. Pregnancy and delivery in woman with congenital heart disease. Circ J. 2015;79:1416–21.

    CAS  Article  Google Scholar 

  4. 4.

    Monteiro RS, Dob DP, Cauldwell MR, Gatzoulis MA. Anaesthetic management of parturients with univentricular congenital heart disease and the Fontan operation. Int J Obstet Anesth. 2016;28:83–91.

    CAS  Article  Google Scholar 

  5. 5.

    Hosking MP, Beynen FM. The modified Fontan procedure: physiology and anesthetic implications. J Cardiothorac Vasc Anesth. 1992;6:465–75.

    CAS  Article  Google Scholar 

  6. 6.

    Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al. Pregnancy and delivery in women after Fontan palliation. Heart. 2006;92:1290–4.

    CAS  Article  Google Scholar 

  7. 7.

    Komori M, Chino T, Takada K, Suzuki H. Anesthetic management for cesarean section in a mother after the Fontan procedure. J Anesth. 1999;13:178–80.

    CAS  Article  Google Scholar 

  8. 8.

    Ioscovich A, Briskin A, Fadeev A, Grisaru-Granovsky S, Halpern S. Emergency cesarean section in a patient with Fontan circulation using an indwelling epidural catheter. J Clin Anesth. 2006;18:631–4.

    CAS  Article  Google Scholar 

  9. 9.

    Mathney E, Beilin Y. Successful epidural anesthesia for cesarean delivery in a woman with Fontan repair. J Clin Anesth. 2015;27:60–2.

    Article  Google Scholar 

  10. 10.

    Saito J, Noguchi S, Nakai K, Midorikawa Y, Kimura F, Hirota K. General anesthetic management for emergency cesarean section and postpartum hemorrhage in a woman with Fontan circulation. J Cardiothorac Vasc Anesth. 2019;33:791–5.

    Article  Google Scholar 

  11. 11.

    Bonner SJ, Asghar O, Roberts A, Vause S, Clarke B, Keavney B. Cardiovascular, obstetric and neonatal outcomes in women with previous Fontan repair. Eur J Obstet Gynecol Reprod Biol. 2017;219:53–6.

    CAS  Article  Google Scholar 

  12. 12.

    Windsor J, Townsley MM, Briston D, Villablanca PA, Alegria JR, Ramakrishna H. Fontan palliation for single-ventricle physiology: perioperative management for noncardiac surgery and analysis of outcomes. J Cardiothorac Vasc Anesth. 2017;31:2296–303.

    Article  Google Scholar 

  13. 13.

    Standl T, Celik L, Weyland C, Haferkorn D, Schulteam Esch J. Microcatheter CSA in a young woman with Fontan repair undergoing elective sterilization. Acta Anaesthesiol Scand. 1997;41:1367–9.

    CAS  Article  Google Scholar 

  14. 14.

    Robosn SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in a cardiac output during human pregnancy. Am J Phys. 1989;256:1060–5.

    Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

Not applicable

Author information

Affiliations

Authors

Contributions

KS was the primary anesthetist and drafted the manuscript. HT and AO supervised the anesthetic management. HT and MY helped to draft the manuscript. The authors read and approved the final manuscript.

Authors’ information

KS is MD, PhD, and Assistant Professor of Anesthesiology and Perioperative Medicine, Tohoku University School of Medicine; HT is MD, PhD, and Lecturer of Anesthesiology and Perioperative Medicine, Tohoku University School of Medicine; AO is MD and Clinical Fellow of Department of Anesthesiology, Tohoku University Hospital; MY is MD, PhD, and Professor of Anesthesiology and Perioperative Medicine, Tohoku University School of Medicine.

Corresponding author

Correspondence to Kazutomo Saito.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

The patient provided informed consent to allow this case report to be published.

Competing interests

The authors have no financial or other conflicts of interest pertinent to this work.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Saito, K., Toyama, H., Okamoto, A. et al. Management of cesarean section in a patient with Fontan circulation: a case report of dramatic reduction of maternal oxygen consumption after delivery. JA Clin Rep 6, 77 (2020). https://doi.org/10.1186/s40981-020-00385-w

Download citation

Keywords

  • Adult congenital heart disease
  • Tricuspid atresia
  • Fontan circulation
  • Cesarean section
  • Central venous oxygen saturation
  • Oxygen consumption